{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:20:32Z","timestamp":1783160432089,"version":"3.54.6"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL178026"],"award-info":[{"award-number":["R01-HL178026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HL131872 S1"],"award-info":[{"award-number":["R01-HL131872 S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009704","name":"Fondazione Ri.Med","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012287","name":"Andrew Sabin Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejphar.2026.178954","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:45:29Z","timestamp":1778309129000},"page":"178954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of the serotonin transporter and risk of heart valve disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"1027","author":[{"given":"Anthony","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6908-6071","authenticated-orcid":false,"given":"Arianna","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Bektik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaagnik","family":"Kosuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Karcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekhar","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8863-2496","authenticated-orcid":false,"given":"Giovanni","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178954_bib1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/cts.13319","article-title":"Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: a population\u2010based cohort study in older adults","volume":"15","author":"Aakj\u00e6r","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.178954_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012503","article-title":"Association of antidepressant medication type with the incidence of cardiovascular disease in the ARIC study","volume":"8","author":"Almuwaqqat","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.178954_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.22385","article-title":"Cardiac and noncardiac fibrotic reactions caused by ergot\u2010and nonergot\u2010derived dopamine agonists","volume":"24","author":"Andersohn","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2026.178954_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000496451","article-title":"A prospective study evaluating the effects of SSRI exposure on cardiac size and function in newborns","volume":"115","author":"Ansah","year":"2019","journal-title":"Neonatology"},{"key":"10.1016\/j.ejphar.2026.178954_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","article-title":"The efficacy and safety of sibutramine for weight loss: a systematic review","volume":"164","author":"Arterburn","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2018.09.009","article-title":"Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?","volume":"140","author":"Ayme-Dietrich","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/fcp.12963","article-title":"Cardiac and hepatic side effects of fluoxetine in male and female adolescent rats","volume":"38","author":"Babaaeyan","year":"2024","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/j.1550-8528.1999.tb00419.x","article-title":"Absence of cardiac valve dysfunction in obese patients treated with sibutramine","volume":"7","author":"Bach","year":"1999","journal-title":"Obesity research"},{"key":"10.1016\/j.ejphar.2026.178954_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.athoracsur.2011.03.084","article-title":"Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness","volume":"92","author":"Balachandran","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejphar.2026.178954_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0074-7742(09)88010-0","article-title":"Neural and cardiac toxicities associated with 3, 4-methylenedioxymethamphetamine (MDMA)","volume":"88","author":"Baumann","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s40263-020-00763-z","article-title":"The cardiovascular effects of newer antidepressants in older adults and those with or at high risk for cardiovascular diseases","volume":"34","author":"Behlke","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.178954_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14740338.2018.1395854","article-title":"Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder","volume":"17","author":"Bello","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2026.178954_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/bdrb.20099","article-title":"First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage","volume":"80","author":"B\u00e9rard","year":"2007","journal-title":"Birth Defects Res. Part B Dev. Reproductive Toxicol."},{"key":"10.1016\/j.ejphar.2026.178954_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00228-016-2187-x","article-title":"Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies","volume":"73","author":"Biffi","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ki.2008.358","article-title":"Role of angiotensin II AT1 receptor activation in cardiovascular diseases","volume":"74","author":"Billet","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2026.178954_bib16","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1523\/JNEUROSCI.21-21-08319.2001","article-title":"Physiological genomics of antidepressant targets: keeping the periphery in mind","volume":"21","author":"Blakely","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178954_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0306-3623(89)90022-0","article-title":"The effects of imipramine, mianserin and trazodone on the chronotropic, inotropic and coronary vascular responses in the isolated perfused rat heart","volume":"20","author":"Boschmans","year":"1989","journal-title":"General pharmacology"},{"key":"10.1016\/j.ejphar.2026.178954_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1471-4159.2007.04542.x","article-title":"Plasma serotonin levels and the platelet serotonin transporter","volume":"102","author":"Brenner","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178954_bib19","series-title":"Antidepressant Use Among Adults","first-page":"2015","author":"Brody","year":"2020"},{"key":"10.1016\/j.ejphar.2026.178954_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107689","article-title":"Serotonin transporter deficiency in mice results in an increased susceptibility to HTR2B-dependent pro-fibrotic mechanisms in the cardiac valves and left ventricular myocardium","volume":"74","author":"Castillero","year":"2025","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.ejphar.2026.178954_bib21","doi-asserted-by":"crossref","first-page":"eadc9606","DOI":"10.1126\/scitranslmed.adc9606","article-title":"Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation","volume":"15","author":"Castillero","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib22","first-page":"V1","article-title":"Antidepressant drugs: mechanisms of action and side effects","volume":"1","author":"Chang","year":"2022","journal-title":"Encyclopedia of Behavioral Neuroscience"},{"key":"10.1016\/j.ejphar.2026.178954_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-017-0612-7","article-title":"Vortioxetine: clinical pharmacokinetics and drug interactions","volume":"57","author":"Chen","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2026.178954_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004185.pub2","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","author":"Cipriani","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.178954_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine\u2013phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molmed.2004.03.007","article-title":"Recent advances in understanding serotonin regulation of cardiovascular function","volume":"10","author":"C\u00f4t\u00e9","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1755-5949.2010.00199.x","article-title":"Nanoparticulate systems for drug delivery and targeting to the central nervous system","volume":"17","author":"Craparo","year":"2011","journal-title":"CNS neuroscience & therapeutics"},{"key":"10.1016\/j.ejphar.2026.178954_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tvjl.2014.12.016","article-title":"Serotonin markers show altered transcription levels in an experimental pig model of mitral regurgitation","volume":"203","author":"Cremer","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.ejphar.2026.178954_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejphar.2011.09.030","article-title":"Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats","volume":"670","author":"Crestani","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib30","first-page":"459","article-title":"Public feelings","volume":"106","author":"Cvetkovich","year":"2007","journal-title":"S. Atl. Q."},{"key":"10.1016\/j.ejphar.2026.178954_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pnpbp.2012.05.003","article-title":"Cardiovascular toxicity of novel psychoactive drugs: lessons from the past","volume":"39","author":"Dawson","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.178954_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/17843286.2015.1125563","article-title":"A happy valve in a happy patient? Serotonergic antidepressants and the risk of valvular heart disease (SERVAL). A case-control study","volume":"71","author":"De Backer","year":"2016","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.ejphar.2026.178954_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.case.2020.11.003","article-title":"A happy patient sheltering an unhappy valve: Serotonin reuptake inhibitor\u2013induced tricuspid valve regurgitation","volume":"5","author":"Defruyt","year":"2021","journal-title":"CASE"},{"key":"10.1016\/j.ejphar.2026.178954_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038273","article-title":"Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus","volume":"7","author":"Derumeaux","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178954_bib35","first-page":"71","article-title":"Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves","volume":"19","author":"Disatian","year":"2010","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.ejphar.2026.178954_bib36","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.amjcard.2007.06.045","article-title":"Possible association between 3, 4-methylenedioxymethamphetamine abuse and valvular heart disease","volume":"100","author":"Droogmans","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.ejphar.2026.178954_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"El Andaloussi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178954_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.etp.2008.03.005","article-title":"5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats","volume":"60","author":"Elangbam","year":"2008","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2026.178954_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2023.100392","article-title":"US Medicaid program: an analysis of the spending and utilization patterns for antidepressants from 2017 to 2021","volume":"13","author":"Elmarasi","year":"2024","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.ejphar.2026.178954_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/neurolint13040049","article-title":"New serotonin-norepinephrine reuptake inhibitors and their anesthetic and analgesic considerations","volume":"13","author":"Fanelli","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.ejphar.2026.178954_bib42","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"The Journal of clinical psychiatry"},{"key":"10.1016\/j.ejphar.2026.178954_bib43","doi-asserted-by":"crossref","DOI":"10.2196\/64016","article-title":"MetaAnalysisOnline. com: web-based tool for the rapid meta-analysis of clinical and epidemiological studies","volume":"27","author":"Fekete","year":"2025","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00392-020-01697-8","article-title":"The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis","volume":"110","author":"Fernandes","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib45","first-page":"714","article-title":"Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use","volume":"38","author":"Forman","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"10.1016\/j.ejphar.2026.178954_bib46","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/heartjnl-2018-314403","article-title":"Drug-associated valvular heart diseases and serotonin-related pathways: a meta-analysis","volume":"105","author":"Fortier","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2026.178954_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010128","article-title":"Benfluorex and unexplained valvular heart disease: a case-control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178954_bib48","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178954_bib49","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.3390\/ijms23105736","article-title":"Fluoxetine treatment decreases cardiac vagal input and alters the serotonergic modulation of the parasympathetic outflow in diabetic rats","volume":"23","author":"Garc\u00eda-Domingo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178954_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2026.178954_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.110.169417","article-title":"Sustained administration of trazodone enhances serotonergic neurotransmission: in vivo electrophysiological study in the rat brain","volume":"335","author":"Ghanbari","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178954_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40265-013-0161-9","article-title":"Vortioxetine: first global approval","volume":"74","author":"Gibb","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2026.178954_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/cvr\/cvx092","article-title":"Serotonin and catecholamines in the development and progression of heart valve diseases","volume":"113","author":"Goldberg","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41467-023-44637-6","article-title":"Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors","volume":"15","author":"Gradisch","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178954_bib55","series-title":"Teratogenicity of SSRIs--serious Concern or Much Ado About Little?","first-page":"2732","author":"Greene","year":"2007"},{"key":"10.1016\/j.ejphar.2026.178954_bib56","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.930255","article-title":"Neurohumoral control of gastrointestinal motility","volume":"52","author":"Hansen","year":"2003","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/pr.2012.183","article-title":"Sertraline exposure leads to small left heart syndrome in adult mice","volume":"73","author":"Haskell","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib59","doi-asserted-by":"crossref","first-page":"H444","DOI":"10.1152\/ajpheart.00763.2012","article-title":"Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure","volume":"304","author":"Henze","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/genes12010086","article-title":"Elevated expression of SLC6A4 encoding the serotonin transporter (SERT) in Gilles de la Tourette syndrome","volume":"12","author":"Hildonen","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.ejphar.2026.178954_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/fcp.12440","article-title":"Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases","volume":"33","author":"Humbert","year":"2019","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease\u2014it was meant 2B","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.ejphar.2026.178954_bib63","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1007\/s12035-016-0304-6","article-title":"Looking beyond the 5-HTTLPR polymorphism: genetic and epigenetic layers of regulation affecting the serotonin transporter gene expression","volume":"54","author":"Iurescia","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/da.22854","article-title":"Systematic review and meta\u2010analysis: Dose\u2013response curve of SSRIs and SNRIs in anxiety disorders","volume":"36","author":"Jakubovski","year":"2019","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2026.178954_bib65","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64489-6","article-title":"Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-\u03b21 via G-protein signal transduction in aortic valve interstitial cells","volume":"161","author":"Jian","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.178954_bib66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gene.2018.09.020","article-title":"5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: a meta-analysis","volume":"680","author":"Jiao","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2026.178954_bib67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1476-5381.1990.tb14108.x","article-title":"A 5-hydroxytryptamine receptor in human atrium","volume":"100","author":"Kaumann","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(24)35098-0","article-title":"Mechanism of sodium channel block by venlafaxine in Guinea pig ventricular myocytes","volume":"291","author":"Khalifa","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178954_bib69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2018.9422","article-title":"Effect of escitalopram vs placebo treatment for depression on long-term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2026.178954_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/YIC.0000000000000238","article-title":"The effect of selective serotonin reuptake inhibitors on major adverse cardiovascular events: a meta-analysis of randomized-controlled studies in depression","volume":"34","author":"Kim","year":"2019","journal-title":"International clinical psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178954_bib71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4088\/JCP.v62n0206","article-title":"Electroconvulsive therapy and cardiovascular complications in patients taking trazodone for insomnia","volume":"62","author":"Krahn","year":"2001","journal-title":"Journal of clinical psychiatry"},{"key":"10.1016\/j.ejphar.2026.178954_bib72","first-page":"197","article-title":"Role and rationale for the use of milnacipran in the management of fibromyalgia","author":"Kranzler","year":"2010","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejphar.2026.178954_bib73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jvc.2011.12.002","article-title":"Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves","volume":"14","author":"Lacerda","year":"2012","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib74","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/14737175.2.6.849","article-title":"SNRIs: mechanism of action and clinical features","volume":"2","author":"Lambert","year":"2002","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2026.178954_bib75","series-title":"Escitalopram, Statpearls [Internet]","author":"Landy","year":"2023"},{"key":"10.1016\/j.ejphar.2026.178954_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM200108023450507","article-title":"Cardiovascular complications of cocaine use","volume":"345","author":"Lange","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib77","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2012.04224.x","article-title":"Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case\u2013control study in the health improvement network (THIN) database","volume":"74","author":"Lapi","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib78","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nature medicine"},{"key":"10.1016\/j.ejphar.2026.178954_bib79","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/bdra.23537","article-title":"In utero exposure to venlafaxine, a serotonin\u2013norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat","volume":"106","author":"Laurent","year":"2016","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejphar.2026.178954_bib80","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7224a1","article-title":"National, state-level, and county-level prevalence estimates of adults aged\u2265 18 years self-reporting a lifetime diagnosis of depression\u2014United States, 2020","volume":"72","author":"Lee","year":"2023","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.ejphar.2026.178954_bib81","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.178954_bib82","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCULATIONAHA.105.593459","article-title":"Serotonin transporter mechanisms and cardiac disease","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib83","doi-asserted-by":"crossref","first-page":"R1216","DOI":"10.1016\/j.cub.2023.09.068","article-title":"Serotonin","volume":"33","author":"Ligneul","year":"2023","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2026.178954_bib84","first-page":"436","article-title":"Colonic serotonin signalling is altered in IBD and IBS","volume":"14","author":"Linden","year":"2002","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2026.178954_bib85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1139\/cjpp-2018-0390","article-title":"Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat","volume":"97","author":"L\u00f3pez","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAF.0000000000000205","article-title":"Cardiac toxicity in selective serotonin reuptake inhibitor users","volume":"36","author":"Lusetti","year":"2015","journal-title":"The American journal of forensic medicine and pathology"},{"key":"10.1016\/j.ejphar.2026.178954_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.acvd.2013.04.006","article-title":"Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study","volume":"106","author":"Mar\u00e9chaux","year":"2013","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10.1016\/j.ejphar.2026.178954_bib88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2010.12.024","article-title":"Role of central serotonin and melanocortin systems in the control of energy balance","volume":"660","author":"Marston","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib89","series-title":"Prescription Drug Use in the United States","first-page":"2015","author":"Martin","year":"2019"},{"key":"10.1016\/j.ejphar.2026.178954_bib90","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0002-9149(01)01435-7","article-title":"Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation","volume":"87","author":"Mast","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/da.22051","article-title":"Treatment of depression in cardiovascular disease","volume":"30","author":"Mavrides","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2026.178954_bib92","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/archinte.164.21.2367","article-title":"Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants","volume":"164","author":"Meijer","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCULATIONAHA.105.554667","article-title":"Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice","volume":"113","author":"Mekontso-Dessap","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib94","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad\u2010Zadeh","year":"2008","journal-title":"J. Vet. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178954_bib95","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib96","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"M\u00f8ller","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pharmthera.2010.08.004","article-title":"Contribution of gene-modified mice and rats to our understanding of the cardiovascular pharmacology of serotonin","volume":"128","author":"Monassier","year":"2010","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.ejphar.2026.178954_bib98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000488364","article-title":"The serotonin transporter gene polymorphisms and risk of ischemic stroke","volume":"45","author":"Mortensen","year":"2018","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2026.178954_bib99","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2013.02.006","article-title":"Worldwide population variation and haplotype analysis at the serotonin transporter gene SLC6A4 and implications for association studies","volume":"74","author":"Murdoch","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178954_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/mi.4.2.8","article-title":"Serotonin transporter: gene, genetic disorders, and pharmacogenetics","volume":"4","author":"Murphy","year":"2004","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ejphar.2026.178954_bib101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coph.2011.02.008","article-title":"Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G\u00d7 G and G\u00d7 E differences in health and disease","volume":"11","author":"Murphy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib102","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jphs.2022.01.004","article-title":"Serotonin transporter: recent progress of in silico ligand prediction methods and structural biology towards structure-guided in silico design of therapeutic agents","volume":"148","author":"Nagayasu","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.178954_bib103","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ahj.2005.03.062","article-title":"Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction","volume":"150","author":"Nakatani","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.178954_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1681.2006.04410.x","article-title":"5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT)","volume":"33","author":"Ni","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib105","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/pharmaceutics15071931","article-title":"Virus-based biological systems as next-generation carriers for the therapy of central nervous system diseases","volume":"15","author":"Nowak","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178954_bib106","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O'Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib107","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"Organization","year":"2017"},{"key":"10.1016\/j.ejphar.2026.178954_bib108","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Owens","year":"1994","journal-title":"Clinical chemistry"},{"key":"10.1016\/j.ejphar.2026.178954_bib109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002109900154","article-title":"Electrophysiological effects of fluoxetine in mammalian cardiac tissues","volume":"361","author":"Pacher","year":"2000","journal-title":"Naunyn-Schmiedeberg's archives of pharmacology"},{"key":"10.1016\/j.ejphar.2026.178954_bib110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/0929867305666220319103330","article-title":"Review of cardiovascular effects of fluoxetine, a selective serotonine reuptake inhibitor, compared to tricyclic antidepressants","volume":"5","author":"Pacher","year":"1998","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178954_bib111","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jamacardio.2021.2247","article-title":"Effect of paroxetine-mediated G-protein receptor kinase 2 inhibition vs placebo in patients with anterior myocardial infarction: a randomized clinical trial","volume":"6","author":"Pilgrim","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib112","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2018.03.458","article-title":"Psychopharmacology and cardiovascular disease","volume":"71","author":"Pi\u00f1a","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib113","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1021\/acs.jpcb.0c06502","article-title":"How monoamine oxidase A decomposes serotonin: an empirical valence bond simulation of the reactive step","volume":"124","author":"Prah","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2026.178954_bib114","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.3390\/ijms12106619","article-title":"Modulation of human serotonin transporter expression by 5-HTTLPR in colon cells","volume":"12","author":"Prasansuklab","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178954_bib115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of escitalopram","volume":"46","author":"Rao","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2026.178954_bib116","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2796.2007.01874.x","article-title":"Heart valve disease associated with treatment with ergot\u2010derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease","volume":"263","author":"Rasmussen","year":"2008","journal-title":"Journal of internal medicine"},{"key":"10.1016\/j.ejphar.2026.178954_bib117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib118","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ebch.786","article-title":"Commentary on \u2018Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)\u2019","volume":"6","author":"Reiersen","year":"2011","journal-title":"Evid. Base Child Health: A Cochrane Review Journal"},{"key":"10.1016\/j.ejphar.2026.178954_bib119","first-page":"9","article-title":"Clinical overview of serotonin reuptake inhibitors","volume":"51","author":"Rickels","year":"1990","journal-title":"The Journal of clinical psychiatry"},{"key":"10.1016\/j.ejphar.2026.178954_bib120","article-title":"Selective SEROTONIN REUPTAKE INHIBITORS (SSRIS)","volume":"397","author":"Rosenblum","year":"2024","journal-title":"Basic Anesthesia Review"},{"key":"10.1016\/j.ejphar.2026.178954_bib121","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14740330902931524","article-title":"Serotonergic drugs and valvular heart disease","volume":"8","author":"Rothman","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2026.178954_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34389-5","article-title":"Two novel, putative mechanisms of action for citalopram-induced platelet inhibition","volume":"8","author":"Roweth","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178954_bib123","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/s41598-018-21348-3","article-title":"Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport","volume":"8","author":"Roweth","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178954_bib124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2017.12.013","article-title":"ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC)","volume":"115","author":"Ryzhov","year":"2018","journal-title":"Journal of molecular and cellular cardiology"},{"key":"10.1016\/j.ejphar.2026.178954_bib125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2016.1160051","article-title":"The preclinical and clinical effects of vilazodone for the treatment of major depressive disorder","volume":"11","author":"Sahli","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.178954_bib126","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.7326\/M22-1507","article-title":"The impact of the COVID-19 pandemic and associated control measures on the mental health of the general population: a systematic review and dose\u2013response meta-analysis","volume":"175","author":"Salanti","year":"2022","journal-title":"Annals of internal medicine"},{"key":"10.1016\/j.ejphar.2026.178954_bib127","first-page":"37","article-title":"Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innovations in clinical neuroscience"},{"key":"10.1016\/j.ejphar.2026.178954_bib128","doi-asserted-by":"crossref","DOI":"10.2337\/dc11-s205","article-title":"Sibutramine on cardiovascular outcome","volume":"34","author":"Scheen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2026.178954_bib129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jvc.2010.06.002","article-title":"Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease","volume":"12","author":"Scruggs","year":"2010","journal-title":"J. Vet. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/15563650701275322","article-title":"QT prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone","volume":"46","author":"Service","year":"2008","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178954_bib131","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3, 4-methylenedioxymethamphetamine (MDMA,\u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2016.12.184","article-title":"Serotonin norepinephrine re-uptake inhibitor (SNRI)-, selective norepinephrine reuptake inhibitor (S-NRI)-, and exogenously administered norepinephrine-induced takotsubo syndrome: analysis of published cases","volume":"231","author":"Shams","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178954_bib133","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12964-023-01195-0","article-title":"The discovery, structure, and function of 5-HTR1E serotonin receptor","volume":"21","author":"Sharma","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2026.178954_bib134","series-title":"Trazodone, Statpearls [Internet]","author":"Shin","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178954_bib135","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/acschemneuro.9b00005","article-title":"The SERT Met172 mouse: an engineered model to elucidate the contributions of serotonin signaling to cocaine action","volume":"10","author":"Simmler","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178954_bib136","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vph.2015.06.015","article-title":"Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment","volume":"73","author":"Simplicio","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends in pharmacological sciences"},{"key":"10.1016\/j.ejphar.2026.178954_bib138","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.echo.2009.05.002","article-title":"Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography","volume":"22","author":"Smith","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ejphar.2026.178954_bib139","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2017.51","article-title":"Non-conventional features of peripheral serotonin signalling\u2014the gut and beyond","volume":"14","author":"Spohn","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178954_bib140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016364","article-title":"Paroxetine attenuates cardiac hypertrophy via blocking GRK2 and ADRB1 interaction in hypertension","volume":"10","author":"Sun","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.178954_bib141","article-title":"Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis","volume":"14","author":"Tan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178954_bib142","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/164_2016_103","article-title":"Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance","author":"Terry","year":"2016","journal-title":"Gastrointestinal Pharmacology"},{"key":"10.1016\/j.ejphar.2026.178954_bib143","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0447.1998.tb09980.x","article-title":"Double\u2010blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode","volume":"97","author":"Tignol","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2026.178954_bib144","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/CIRCULATIONAHA.112.111260","article-title":"Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study","volume":"126","author":"Tribouilloy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178954_bib145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib146","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fgene.2019.00898","article-title":"Potential adverse cardiovascular effects of treatment with fluoxetine and other selective serotonin reuptake inhibitors (SSRIs) in patients with geriatric depression: implications for atherogenesis and cerebromicrovascular dysregulation","volume":"10","author":"Ungvari","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejphar.2026.178954_bib147","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1139\/jpn.0646","article-title":"Concerns regarding antidepressant drug use during pregnancy","volume":"31","author":"Urato","year":"2006","journal-title":"Journal of psychiatry & neuroscience"},{"key":"10.1016\/j.ejphar.2026.178954_bib148","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","article-title":"Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity","volume":"55","author":"Vaishnavi","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178954_bib149","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jacbts.2023.06.014","article-title":"Development of a peripherally restricted 5-HT2B partial agonist for treatment of pulmonary arterial hypertension","volume":"8","author":"Valentine","year":"2023","journal-title":"Basic to Translational Science"},{"key":"10.1016\/j.ejphar.2026.178954_bib150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(00)00814-1","article-title":"Pharmacogenetics and the serotonin system: initial studies and future directions","volume":"410","author":"Veenstra-VanderWeele","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178954_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.774573","article-title":"Serotonin\u2014A driver of progressive heart valve disease","volume":"9","author":"Waldum","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.178954_bib152","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41422-023-00906-z","article-title":"Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines","volume":"34","author":"Wang","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2026.178954_bib153","first-page":"86","article-title":"Vasoactive agents alter the biomechanical properties of aortic heart valve leaflets in a time-dependent manner","volume":"19","author":"Warnock","year":"2010","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.ejphar.2026.178954_bib154","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","article-title":"Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus","volume":"19","author":"Weill","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2026.178954_bib155","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","article-title":"Cardiovascular safety of psychedelic medicine: current status and future directions","volume":"75","author":"Ws\u00f3\u0142","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2026.178954_bib156","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1039\/C5CP05771J","article-title":"Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study","volume":"18","author":"Xue","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejphar.2026.178954_bib157","first-page":"169","article-title":"Cardiovascular considerations in antidepressant therapy: an evidence-based review","volume":"8","author":"Yekehtaz","year":"2013","journal-title":"J. Tehran Univ. Heart Cent."},{"key":"10.1016\/j.ejphar.2026.178954_bib158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/14017431.2014.886335","article-title":"Venous plasma serotonin is not a proper biomarker for pulmonary arterial hypertension","volume":"48","author":"Zeinali","year":"2014","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ejphar.2026.178954_bib159","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12872-023-03378-6","article-title":"Selective serotonin reuptake inhibitors regulate the interrelation between 5-HT and inflammation after myocardial infarction","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:08:34Z","timestamp":1783159714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992600436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":159,"alternative-id":["S001429992600436X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178954","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the serotonin transporter and risk of heart valve disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178954"}}